Founder, Pritchett Policy Associates Senior Associate, Center for Strategic & International Studies Innovation policies, biopharma supply chain, US leadership
Virginia
Joined February 2025
- Tweets664
- Following219
- Followers62
- Likes130
Celebrating 50 years of the Copyright Act! recently celebrated its 50th anniversary. Learn more about how this law supports authors, musicians, filmmakers, and other creators in bringing their creativity to all of us: @CopyrightOffice: copyright.gov/events/copyrig…
Did you know that about 70% of university licensing agreements are with start ups & emerging companies? Learn more as @InsideSourcesDC, @SBECouncil's @KarenKerrigan explains how the Bayh-Dole Act fuels innovation: dcjournal.com/americas-innov…
Paperwork errors shouldn’t undermine decades of research. Congress should reject the Medication Affordability and Patent Integrity Act. Learn more: ipwatchdog.com/2026/10/21/do…
Great woman inventor story In @bizwomen. Sabrina Kemeny talks about how developing cameras for NASA fueled her entrepreneurial spirit and how tech transfer helped bring the "camera-on-a-chip" to market: bizjournals.com/bizjournals/…
Important read that reinforces need to expand incentives to address AMR and to ensure appropriate prescriber education
Drug-resistant infections are already placing a significant financial burden on U.S. hospitals, and that burden could grow substantially over the next two decades.
Our recent antimicrobial resistance (AMR) study estimates that annual U.S. hospital costs associated with resistant infections could rise from approximately $31 billion in 2025 to $52 billion by 2045, an increase of nearly 68%.
#AMR #AntimicrobialResistance #HealthEconomics
If you love to read a good invention story, check out this blog to learn more about four historic inventions, and the patents behind them @Council4IP: c4ip.org/celebrating-ip-mont…
The COINS Act is a misguided attempt to deter China’s competitiveness but government overreach here could impede U.S. global competitiveness, slow the pace of medical innovation, & leave the U.S. further behind in access to new & emerging technologies that benefit U.S. patients.
The COINS Act—cute name but bad policy—government is overreaching when it seeks to impede American companies from making investments in legitimate businesses that could further fuel U.S. innovation & grow the U.S. economy. How does that help America compete globally?
Research into new technologies has never been more promising. But to bring innovation forward requires a strong IP system. Learn more from @Council4IP Advisory Board Member Laura Peter in this Q&A from @USChamber: uschamber.com/intellectual-p…
Get the facts on terminal disclaimers from @Council4IP: c4ip.org/fact-check-correcti…
Receiving any federal funding should never mean the government then owns the invention. In a new IPWatchdog piece, @BayhDole's Joe Allen explains how such proposals would undermine the U.S. transfer system and impede the pace of innovation. Read it: ipwatchdog.com/2026/10/15/ab…
Patients don’t often think about patents they just want access to lifesaving medicines. But patents are what fuels the R&D that leads to new treatments & cures for patients. Check out @EIRAInitiative to learn more about IP: linkedin.com/pulse/how-right…
Counterfeits & Halloween—did you know that fake costumes & other items can contain dangerous chemicals that could harm you? Learn more from @USChamber to avoid getting tricked & harmed this spooky season: uschamber.com/intellectual-p…
On @FederalNewsNet, @BayhDole's Joe Allen explains how protecting Bayh-Dole is key to supporting U.S. global competitiveness. Listen: federalnewsnetwork.com/podca…
Get the facts on how science & the U.S. patent system supported the research & development that led to GLP-1 medicines. Read more from @EiraInitiative Co-Director Dr. Bowman Heiden in @FortuneMagazine:fortune.com/2026/10/10/glp1-…
The U.S. remains one of the world's most innovative countries in this year's Global Innovation Index from @WIPO. But to keep attracting investment & growing our economy we must defend against efforts to erode IP rights of U.S. inventors. Learn more: wipo.int/en/web/global-innov…
It’s Intellectual Property Month! Great time to learn more about innovation fueled by the U.S. patent system over more than two centuries: uspto.gov/patents/milestones
"Patent thickets." "Evergreening." "Product hopping." These labels are too often used to attack the very innovations that lead to better medicines. Coke Stewart's sets the record straight on patents and medical innovation in @IPwatchdog. Worth a read: ipwatchdog.com/2026/10/04/wh…
Who doesn’t love a great infographic!?! Check out new @BayhDole graphic showing the economic impacts of the Bayh-Dole Act over the past few decades: bayhdolecoalition.org/wp-con…
Check out the new @CenterforIP's podcast with Corey Salsberg to learn more about IP’s role in driving the U.S. economy. Listen here: buzzsprout.com/1537696/episo…
